logo

DOCS

Doximity·NYSE
--
--(--)
--
--(--)
7.38 / 10
Outperform

Financial evaluation rates DOCS at 7.4/10, highlighting strengths in Revenue-MV, Cash-MV, and Asset-MV, while PB-ROE and asset turnover are weaknesses. The positive fundamentals provide a cushion, though return metrics like ROA are negative, indicating room for improvement.

Fundamental(7.38)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-0.26
Score2/3
Weight9.90%
1M Return7.23%
Days sales outstanding
Value72.48
Score0/3
Weight-1.96%
1M Return-1.40%
Profit-MV
Value-0.80
Score3/3
Weight10.57%
1M Return7.59%
Net income-Revenue
Value0.98
Score2/3
Weight4.08%
1M Return3.05%
PB-ROE
Value9.87
Score1/3
Weight0.05%
1M Return0.04%
Rate of return on total assets (%)
Value-7.69
Score1/3
Weight1.30%
1M Return0.99%
Annualized return on total assets (%)
Value-7.69
Score1/3
Weight1.30%
1M Return0.99%
Asset-MV
Value-0.50
Score3/3
Weight62.88%
1M Return27.51%
Inventory turnover days
Value300.47
Score3/3
Weight2.02%
1M Return1.44%
Cash-MV
Value-0.64
Score3/3
Weight9.86%
1M Return6.31%
Is DOCS fundamentally strong?
  • DOCS scores 7.38/10 on fundamentals and holds a Discounted valuation at present. Backed by its 17.16% ROE, 37.54% net margin, 21.40 P/E ratio, 5.23 P/B ratio, and 17.59% earnings growth, these metrics solidify its Outperform investment rating.